(Q63394885)
Statements
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability and Efficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects With Alopecia Areata, Alopecia Universalis or Alopecia Totalis (English)
0 references
11 June 2018
0 references
16 April 2019
0 references
87
0 references
18 year
0 references